JPH10502702A - 分析および/またはリファレンシング用の発電化学発光標識 - Google Patents
分析および/またはリファレンシング用の発電化学発光標識Info
- Publication number
- JPH10502702A JPH10502702A JP8524293A JP52429396A JPH10502702A JP H10502702 A JPH10502702 A JP H10502702A JP 8524293 A JP8524293 A JP 8524293A JP 52429396 A JP52429396 A JP 52429396A JP H10502702 A JPH10502702 A JP H10502702A
- Authority
- JP
- Japan
- Prior art keywords
- ecl
- thcooh
- bpy
- dpas
- reactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 13
- 238000010248 power generation Methods 0.000 title claims description 8
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000000376 reactant Substances 0.000 claims abstract description 29
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960001076 chlorpromazine Drugs 0.000 claims abstract description 7
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims abstract description 6
- BLJIAZIZIXSNJZ-UHFFFAOYSA-N thianthrene-2-carboxylic acid Chemical class C1=CC=C2SC3=CC(C(=O)O)=CC=C3SC2=C1 BLJIAZIZIXSNJZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 101100117387 Catharanthus roseus DPAS gene Proteins 0.000 claims abstract 3
- PHSNTEKLPXCHFV-UHFFFAOYSA-M sodium;9,10-diphenylanthracene-2-sulfonate Chemical compound [Na+].C=12C=CC=CC2=C(C=2C=CC=CC=2)C2=CC(S(=O)(=O)[O-])=CC=C2C=1C1=CC=CC=C1 PHSNTEKLPXCHFV-UHFFFAOYSA-M 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 32
- 238000004020 luminiscence type Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- -1 polycyclic compound Chemical class 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 125000003367 polycyclic group Chemical group 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 239000012491 analyte Substances 0.000 claims description 5
- 108020003215 DNA Probes Proteins 0.000 claims description 4
- 239000003298 DNA probe Substances 0.000 claims description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 4
- 229910052707 ruthenium Inorganic materials 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000004305 biphenyl Substances 0.000 claims description 2
- 229910052762 osmium Inorganic materials 0.000 claims description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 150000001491 aromatic compounds Chemical class 0.000 claims 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 abstract description 50
- 230000003647 oxidation Effects 0.000 abstract description 47
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract description 23
- 230000009467 reduction Effects 0.000 abstract description 18
- 239000007864 aqueous solution Substances 0.000 abstract description 16
- 230000007246 mechanism Effects 0.000 abstract description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- 239000000243 solution Substances 0.000 description 22
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 238000002484 cyclic voltammetry Methods 0.000 description 18
- 238000001228 spectrum Methods 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 230000008569 process Effects 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 12
- 239000012064 sodium phosphate buffer Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 230000005284 excitation Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- GVIJJXMXTUZIOD-UHFFFAOYSA-N thianthrene Chemical compound C1=CC=C2SC3=CC=CC=C3SC2=C1 GVIJJXMXTUZIOD-UHFFFAOYSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 230000005518 electrochemistry Effects 0.000 description 8
- 230000005281 excited state Effects 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000033116 oxidation-reduction process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000003115 supporting electrolyte Substances 0.000 description 4
- OURODNXVJUWPMZ-UHFFFAOYSA-N 1,2-diphenylanthracene Chemical class C1=CC=CC=C1C1=CC=C(C=C2C(C=CC=C2)=C2)C2=C1C1=CC=CC=C1 OURODNXVJUWPMZ-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 description 3
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000006114 decarboxylation reaction Methods 0.000 description 3
- UNXNGGMLCSMSLH-UHFFFAOYSA-N dihydrogen phosphate;triethylazanium Chemical compound OP(O)(O)=O.CCN(CC)CC UNXNGGMLCSMSLH-UHFFFAOYSA-N 0.000 description 3
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000002427 irreversible effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 229960003598 promazine Drugs 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 235000011008 sodium phosphates Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000006276 transfer reaction Methods 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- AUKRYONWZHRJRE-UHFFFAOYSA-N 9-anthrol Chemical compound C1=CC=C2C(O)=C(C=CC=C3)C3=CC2=C1 AUKRYONWZHRJRE-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- AKUVRZKNLXYTJX-UHFFFAOYSA-N 3-benzylazetidine Chemical class C=1C=CC=CC=1CC1CNC1 AKUVRZKNLXYTJX-UHFFFAOYSA-N 0.000 description 1
- GIKNHHRFLCDOEU-UHFFFAOYSA-N 4-(2-aminopropyl)phenol Chemical compound CC(N)CC1=CC=C(O)C=C1 GIKNHHRFLCDOEU-UHFFFAOYSA-N 0.000 description 1
- FCNCGHJSNVOIKE-UHFFFAOYSA-N 9,10-diphenylanthracene Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 FCNCGHJSNVOIKE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 238000007743 anodising Methods 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- BRABPYPSZVCCLR-UHFFFAOYSA-N methopromazine Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC(OC)=CC=C3SC2=C1 BRABPYPSZVCCLR-UHFFFAOYSA-N 0.000 description 1
- 229950008620 methopromazine Drugs 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- GIDFDWJDIHKDMB-UHFFFAOYSA-N osmium ruthenium Chemical compound [Ru].[Os] GIDFDWJDIHKDMB-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000005839 radical cations Chemical class 0.000 description 1
- 150000005837 radical ions Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- XGQPUSJLJAPLGH-UHFFFAOYSA-M sodium;anthracene-2-sulfonate Chemical compound [Na+].C1=CC=CC2=CC3=CC(S(=O)(=O)[O-])=CC=C3C=C21 XGQPUSJLJAPLGH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- WGHUNMFFLAMBJD-UHFFFAOYSA-M tetraethylazanium;perchlorate Chemical compound [O-]Cl(=O)(=O)=O.CC[N+](CC)(CC)CC WGHUNMFFLAMBJD-UHFFFAOYSA-M 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Dental Preparations (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 発電化学発光組成物において、所望によりNおよびSから選択される少 なくとも1個のヘテロ原子で置換された環炭素およびRu(bpy)3 2+の発光 波長から区別される発光波長を有する置換多環化合物、および電気化学エネルギ ーの存在下では発電化学発光を生じる共反応物を含んでなる組成物。 2. 共反応物が存在し、トリ−n−プロピルアミン(TPrA)またはペル オキシジスルフェート(S2O8 2-)を含む、請求の範囲1に記載の組成物。 3. 前記多環化合物が芳香族性の発光化合物である、請求の範囲1に記載の 組成物。 4. 前記芳香族化合物が、少なくとも1個のヘテロ原子で置換した環炭素を 有する、請求の範囲3に記載の組成物。 5. 前記ヘテロ原子がNおよびSから選択される、請求の範囲3に記載の組 成物。 6. 前記芳香族化合物が、9,10−ジフェニルアントラセン−2−スルホ ン酸ナトリウム(DPAS)、1−および2−チアントレンカルボン酸(1−T HCOOHおよび2−THCOOH)、およびクロルプロマジンからなる群から 選択される、請求の範囲3に記載の組成物。 7. a)所望により少なくとも1個のNまたはSヘテロ原子で置換された環 炭素を有する置換多環芳香族標識を有するバイオ分子を提供し、 b)共反応物を提供し、 c)標識したバイオ分子および共反応物を電気化学エネルギーに暴露し、生成 するルミネッセンスを測定する ことを含んでなる、分析物の検出法。 8. 前記標識がRu(bpy)3 2+の発光波長から区別される発光波長を有 する、請求の範囲7に記載の方法。 9. 複数の分析物を検出する方法において、 a)Ru(bpy)3 2+の発光波長から区別される発光波長を有する発光標識を 有する少なくとも1個の第一のバイオ分子の分析物を提供し、 b)ルテニウムまたはオスミウムを含む標識を有する第二のバイオ分子分析物 を提供し、 c)少なくとも1個の共反応物を加え、 d)標識したバイオ分子分析物および共反応物を電気化学エネルギーに暴露し 、生成するルミネッセンスを測定して、含まれている各種のバイオ分子分析物を 検出する ことを含んでなる、方法。 10. Ru(bpy)3 2+・の発光波長から区別される発光波長を有する前記 標識が、所望により少なくとも1個のNまたはSヘテロ原子で置換された環炭素 を有する置換多環芳香族標識である、請求の範囲9に記載の方法。 11. Ru(bpy)3 2+・の発光波長から区別される発光波長を有する前記 標識が、9,10−ジフェニルアントラセン−2−スルホン酸ナトリウム(DP AS)、1−および2−チアントレンカルボン酸(1−THCOOHおよび2− THCOOH)、クロルプロマジンから選択される、請求の範囲9に記載の方法 。 12. 前記の発電化学発光が、前記標識および前記共反応物または同等な環 置換体の反応から生じる、請求の範囲7に記載の方法。 13. トリプロピルアミン共反応物が存在する、請求の範囲7に記載の方法 。 14. 前記バイオ分子が、抗体、抗原、またはDNAプローブである、請求 の範囲7に記載の方法。 15. 前記の発電化学発光が、前記標識および前記共反応物の反応から生じ る、請求の範囲9に記載の方法。 16. トリプロピルアミン共反応物が存在する、請求の範囲9に記載の方法 。 17. 前記バイオ分子が、抗体、抗原、またはDNAプローブである、請求 の範囲9に記載の方法。 18. 前記標識がクロルプロマジンである、請求の範囲7または9に記載の 方法。 19. 前記の共反応物が前記多環化合物上で置換した残基である、請求の範 囲1に記載の組成物。 20. 前記共反応物が前記多環化合物上で置換した残基である、請求の範囲 7または9に記載の組成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/385,864 | 1995-02-09 | ||
| US08/385,864 US5786141A (en) | 1994-08-26 | 1995-02-09 | Electrogenerated chemiluminescence labels for analysis and/or referencing |
| PCT/US1996/001113 WO1996024690A1 (en) | 1995-02-09 | 1996-02-09 | Electrogenerated chemiluminescence labels for analysis and/or referencing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10502702A true JPH10502702A (ja) | 1998-03-10 |
| JP3989019B2 JP3989019B2 (ja) | 2007-10-10 |
Family
ID=23523173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52429396A Expired - Lifetime JP3989019B2 (ja) | 1995-02-09 | 1996-02-09 | 分析および/またはリファレンシング用の発電化学発光標識 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5786141A (ja) |
| EP (1) | EP0755458B1 (ja) |
| JP (1) | JP3989019B2 (ja) |
| AT (1) | ATE274601T1 (ja) |
| AU (1) | AU709592B2 (ja) |
| CA (1) | CA2186503C (ja) |
| DE (1) | DE69633212T2 (ja) |
| DK (1) | DK0755458T3 (ja) |
| ES (1) | ES2227580T3 (ja) |
| PT (1) | PT755458E (ja) |
| WO (1) | WO1996024690A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015522801A (ja) * | 2012-05-15 | 2015-08-06 | ウェルスタット ダイアグノスティクス,エルエルシー | 臨床診断システム |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010003647A1 (en) * | 1995-06-07 | 2001-06-14 | Ji Sun | Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| US6319670B1 (en) | 1995-05-09 | 2001-11-20 | Meso Scale Technology Llp | Methods and apparatus for improved luminescence assays using microparticles |
| US6613583B1 (en) | 1997-06-27 | 2003-09-02 | Igen International, Inc. | Electrochemiluminescent label based on multimetallic assemblies |
| US6153674A (en) * | 1998-01-30 | 2000-11-28 | 3M Innovative Properties Company | Fire barrier material |
| US6200531B1 (en) * | 1998-05-11 | 2001-03-13 | Igen International, Inc. | Apparatus for carrying out electrochemiluminescence test measurements |
| US7186568B1 (en) | 2000-06-26 | 2007-03-06 | Lumigen Inc. | Electrochemiluminescence from acridan compounds |
| JP2006170615A (ja) * | 2001-01-19 | 2006-06-29 | Shigeori Takenaka | 遺伝子の検出方法、検出装置、並びに検出用チップ |
| DK1412725T3 (en) | 2001-06-29 | 2019-03-25 | Meso Scale Technologies Llc | Multi-well plates for LUMINESCENSE TEST MEASUREMENTS |
| EP1412487B1 (en) | 2001-07-30 | 2010-06-16 | Meso Scale Technologies LLC | Assay electrodes having immobilized lipid/protein layers and methods of making and using the same |
| AU2002341621A1 (en) | 2001-09-10 | 2003-03-24 | Meso Scale Technologies, Llc | Methods, reagents, kits and apparatus for protein function analysis |
| KR20050013592A (ko) * | 2002-06-20 | 2005-02-04 | 아이젠인터내셔널인코포레이티드 | 전기화학발광 유동 셀 및 유동 셀 성분 |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
| US8989833B2 (en) | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| EP1830183A1 (en) * | 2004-12-21 | 2007-09-05 | Kyoto University | Probe unit, apparatus for identifying nucleotide region and method of identifying nucleotide region |
| WO2006076650A2 (en) * | 2005-01-12 | 2006-07-20 | Applera Corporation | Compositions, methods, and kits for selective amplification of nucleic acids |
| JP5590796B2 (ja) * | 2005-06-03 | 2014-09-17 | ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム | 電気化学および単一ファラデー電極による電気化学発光 |
| PT2271938E (pt) | 2008-04-11 | 2014-05-09 | Univ Texas | Método e aparelho de amplificação de quimiluminescênci electrogerada por nanopartículas |
| AU2009244904B2 (en) | 2008-05-08 | 2014-04-17 | Board Of Regents Of The University Of Texas System | Luminescent nanostructured materials for use in electrogenerated chemiluminescence |
| US20100261292A1 (en) | 2009-04-10 | 2010-10-14 | Meso Scale Technologies, Llc | Methods for Conducting Assays |
| EP2470914B1 (en) | 2009-07-27 | 2020-05-13 | Meso Scale Technologies, LLC | Assay apparatuses and methods |
| JP5943927B2 (ja) | 2010-10-14 | 2016-07-05 | メソ スケール テクノロジーズ エルエルシー | アッセイデバイスにおける試薬貯蔵 |
| BR112013007614B1 (pt) | 2010-10-25 | 2020-12-29 | F. Hoffmann-La Roche Ag | método para medir um analito, composição reagente, mistura reagente, uso de uma composição reagente, uso de uma amida de ácido carbônico e kit |
| EP2776833B1 (en) | 2011-11-11 | 2018-09-05 | Eli N. Glezer | Co-binder assisted assay methods |
| US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
| US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
| CA3235305A1 (en) | 2013-01-04 | 2014-07-10 | Meso Scale Technologies, Llc. | Assay apparatuses, methods and reagents |
| DK2972353T3 (da) | 2013-03-11 | 2023-03-27 | Meso Scale Technologies Llc | Forbedrede fremgangsmåder til udførelse af multipleksanalyser |
| US10114015B2 (en) | 2013-03-13 | 2018-10-30 | Meso Scale Technologies, Llc. | Assay methods |
| CA2904181A1 (en) | 2013-03-13 | 2014-10-09 | Anahit Aghvanyan | Sandwich immunoassay comprising anchoring reagent |
| US10202500B2 (en) | 2013-03-15 | 2019-02-12 | Lubrizol Advanced Materials, Inc. | Heavy metal free CPVC compounds |
| CA3229509A1 (en) | 2014-05-09 | 2015-11-12 | Meso Scale Technologies, Llc. | Graphene-modified electrodes |
| EP3143401A4 (en) | 2014-05-15 | 2017-10-11 | Meso Scale Technologies, LLC | Improved assay methods |
| CN104297231A (zh) * | 2014-10-30 | 2015-01-21 | 中国科学院长春应用化学研究所 | 一种电化学发光光谱仪 |
| JP6979941B2 (ja) | 2015-08-20 | 2021-12-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Peg化分析物特異的結合剤を用いた粒子に基づくイムノアッセイ |
| BR112018017336A2 (pt) | 2016-03-07 | 2018-12-26 | Hoffmann La Roche | método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão |
| WO2017153574A1 (en) | 2016-03-11 | 2017-09-14 | Roche Diagnostics Gmbh | Branched-chain amines in electrochemiluminescence detection |
| JP7068323B2 (ja) | 2017-02-02 | 2022-05-16 | エフ.ホフマン-ラ ロシュ アーゲー | 少なくとも2種のペグ化された分析物特異的結合剤を使用する免疫アッセイ |
| FI127861B (en) | 2017-06-29 | 2019-04-15 | Labmaster Oy | A method and a device for dynamic generation of hot electrons into aqueous solutions |
| EP4310184A3 (en) | 2018-02-23 | 2024-05-01 | Meso Scale Technologies, LLC. | Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule |
| EP3781600A1 (en) | 2018-04-18 | 2021-02-24 | F. Hoffmann-La Roche AG | Novel anti-thymidine kinase antibodies |
| JP7577647B2 (ja) | 2018-08-31 | 2024-11-05 | エフ. ホフマン-ラ ロシュ アーゲー | Dlbclについての予後指標におけるチミジンキナーゼ(tk-1) |
| KR102821103B1 (ko) * | 2018-12-17 | 2025-06-13 | 일루미나, 인코포레이티드 | 유동 셀 및 시퀀싱 키트 |
| AU2019418498A1 (en) | 2019-01-03 | 2021-07-15 | Meso Scale Technologies, Llc | Compositions and methods for carrying out assay measurements |
| CN120098057A (zh) | 2019-03-01 | 2025-06-06 | 中尺度技术有限责任公司 | 用于免疫方法的被电化学发光标记的探针、使用这类探针的方法和包含这类探针的试剂盒 |
| CN120665985A (zh) | 2019-06-07 | 2025-09-19 | 豪夫迈·罗氏有限公司 | 杂交全lna寡核苷酸 |
| IL325928A (en) | 2019-07-16 | 2026-03-01 | Meso Scale Technologies Llc | Testing instruments, methods and reagents |
| WO2021013783A1 (en) | 2019-07-22 | 2021-01-28 | F. Hoffmann-La Roche Ag | S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis |
| WO2021013785A1 (en) | 2019-07-22 | 2021-01-28 | F. Hoffmann-La Roche Ag | S100a9 as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4004555A1 (en) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4004551A1 (en) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | Substance p as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4004553A1 (en) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | S100a8 as blood biomarker for the non-invasive diagnosis of endometriosis |
| CN110501406B (zh) * | 2019-09-30 | 2021-11-19 | 青岛大学 | 一种基于石墨烯电极的亚精胺电化学发光检测法 |
| KR20220100883A (ko) | 2019-11-15 | 2022-07-18 | 에프. 호프만-라 로슈 아게 | 환자 샘플의 질량분석법 측정을 위한 베타-락탐 항생제의 유도체화 |
| US20240018571A1 (en) | 2020-05-19 | 2024-01-18 | Meso Scale Technologies, Llc. | Methods, compositions, and kits for nucleic acid detection |
| EP4176263A1 (en) | 2020-07-01 | 2023-05-10 | Meso Scale Technologies, LLC | Compositions and methods for assay measurements |
| JP7851928B2 (ja) | 2020-11-02 | 2026-04-27 | エフ. ホフマン-ラ ロシュ アーゲー | SARS-CoV-2ヌクレオカプシド抗体 |
| JP2023554517A (ja) | 2020-12-22 | 2023-12-27 | エフ. ホフマン-ラ ロシュ アーゲー | 試料中の目的の分析物を検出するための方法 |
| WO2022207628A1 (en) | 2021-03-30 | 2022-10-06 | F. Hoffmann-La Roche Ag | Scf as blood biomarker for the non-invasive diagnosis of endometriosis |
| WO2022207685A1 (en) | 2021-04-01 | 2022-10-06 | F. Hoffmann-La Roche Ag | Psp94 as blood biomarker for the non-invasive diagnosis of endometriosis |
| CN117337394A (zh) | 2021-05-17 | 2024-01-02 | 豪夫迈·罗氏有限公司 | sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断 |
| AU2022304570A1 (en) | 2021-06-28 | 2024-01-18 | Meso Scale Technologies, Llc. | Methods, compositions, and kits for assay signal amplification |
| WO2023072904A1 (en) | 2021-10-26 | 2023-05-04 | F. Hoffmann-La Roche Ag | Monoclonal antibodies specific for sars-cov-2 rbd |
| CN118922555A (zh) | 2021-12-30 | 2024-11-08 | 中尺度技术有限责任公司 | 用于电化学发光检测的方法 |
| WO2023131594A1 (en) | 2022-01-05 | 2023-07-13 | F. Hoffmann-La Roche Ag | Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm) |
| JP2025506652A (ja) | 2022-02-18 | 2025-03-13 | エフ. ホフマン-ラ ロシュ アーゲー | 試料中の目的の分析物を検出するための方法 |
| US20250244342A1 (en) | 2022-04-07 | 2025-07-31 | Meso Scale Technologies, Llc. | Methods and kits for assessing alzheimer's disease |
| JP2025520600A (ja) | 2022-06-23 | 2025-07-03 | エフ. ホフマン-ラ ロシュ アーゲー | 子宮内膜症を診断するためおよび子宮内膜症の病期を分類するための方法 |
| JP2025524027A (ja) | 2022-07-22 | 2025-07-25 | エフ. ホフマン-ラ ロシュ アーゲー | 多嚢胞性卵巣症候群の診断のための(血液)バイオマーカーとしてのメテオリン様タンパク質(metrnl) |
| EP4558826A1 (en) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome |
| EP4558830A1 (en) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome |
| AU2023408595A1 (en) | 2022-12-20 | 2025-07-17 | Meso Scale Technologies, Llc. | Assay methods and kits |
| CN121532654A (zh) | 2023-07-20 | 2026-02-13 | 豪夫迈·罗氏有限公司 | 针对抗体组合物的筛选方法 |
| CN121752901A (zh) | 2023-07-28 | 2026-03-27 | 豪夫迈·罗氏有限公司 | 作为子宫内膜异位症的生物标志物的血清EphA1 |
| WO2025260043A1 (en) | 2024-06-14 | 2025-12-18 | Meso Scale Technologies, Llc. | Methods and kits for measuring three or more tau epitopes |
| WO2026039455A1 (en) | 2024-08-13 | 2026-02-19 | Meso Scale Technologies, Llc. | Detection of nucleic acids |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3442816A (en) * | 1966-02-23 | 1969-05-06 | American Cyanamid Co | Generation of light by the reaction of tetracyanoethylene or other electronegatively substituted ethylene,ethylene oxide and carbonyl compound with hydrogen peroxide in the presence of a fluorescer |
| US5238808A (en) * | 1984-10-31 | 1993-08-24 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5310687A (en) * | 1984-10-31 | 1994-05-10 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5221605A (en) * | 1984-10-31 | 1993-06-22 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| JPH01305069A (ja) * | 1988-05-31 | 1989-12-08 | Shionogi & Co Ltd | ベンゾトリアゾール誘導体およびそれを含有する発螢光試薬 |
| US5324457A (en) * | 1989-10-02 | 1994-06-28 | Board Of Regents, The University Of Tx System | Devices and methods for generating electrogenerated chemiluminescence |
| US5340714A (en) * | 1992-05-08 | 1994-08-23 | Monitor Diagnostics, Inc. | Use of nonmetallic tetrapyrrole molecules and novel signal solutions in chemiluminescent reactions and assays |
| JPH10509025A (ja) * | 1994-08-26 | 1998-09-08 | アイジェン, インコーポレイテッド | 固体表面に吸着された核酸の電気的に発生した化学ルミネッセンス性検出のためのバイオセンサーおよび方法 |
-
1995
- 1995-02-09 US US08/385,864 patent/US5786141A/en not_active Expired - Lifetime
-
1996
- 1996-02-09 EP EP96903716A patent/EP0755458B1/en not_active Expired - Lifetime
- 1996-02-09 ES ES96903716T patent/ES2227580T3/es not_active Expired - Lifetime
- 1996-02-09 AU AU47708/96A patent/AU709592B2/en not_active Expired
- 1996-02-09 CA CA002186503A patent/CA2186503C/en not_active Expired - Lifetime
- 1996-02-09 DK DK96903716T patent/DK0755458T3/da active
- 1996-02-09 PT PT96903716T patent/PT755458E/pt unknown
- 1996-02-09 DE DE69633212T patent/DE69633212T2/de not_active Expired - Lifetime
- 1996-02-09 AT AT96903716T patent/ATE274601T1/de active
- 1996-02-09 WO PCT/US1996/001113 patent/WO1996024690A1/en not_active Ceased
- 1996-02-09 JP JP52429396A patent/JP3989019B2/ja not_active Expired - Lifetime
-
1998
- 1998-05-20 US US09/082,273 patent/US6479233B1/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015522801A (ja) * | 2012-05-15 | 2015-08-06 | ウェルスタット ダイアグノスティクス,エルエルシー | 臨床診断システム |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69633212D1 (de) | 2004-09-30 |
| ES2227580T3 (es) | 2005-04-01 |
| AU709592B2 (en) | 1999-09-02 |
| EP0755458A4 (en) | 2000-07-26 |
| ATE274601T1 (de) | 2004-09-15 |
| EP0755458A1 (en) | 1997-01-29 |
| AU4770896A (en) | 1996-08-27 |
| US6479233B1 (en) | 2002-11-12 |
| DK0755458T3 (da) | 2004-11-29 |
| JP3989019B2 (ja) | 2007-10-10 |
| EP0755458B1 (en) | 2004-08-25 |
| DE69633212T2 (de) | 2005-09-22 |
| WO1996024690A1 (en) | 1996-08-15 |
| CA2186503C (en) | 2007-01-23 |
| PT755458E (pt) | 2005-01-31 |
| CA2186503A1 (en) | 1996-08-15 |
| US5786141A (en) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH10502702A (ja) | 分析および/またはリファレンシング用の発電化学発光標識 | |
| Wu et al. | Recent developments in the detection of singlet oxygen with molecular spectroscopic methods | |
| JP5882054B2 (ja) | 反応種検出のためのルミネセンス消光剤及び発蛍光型プローブ | |
| Kayani et al. | Carbon dot as fluorescence sensor for glutathione in human serum samples: a review | |
| CN102146284B (zh) | 一种比率型荧光探针及其应用 | |
| Ciscato et al. | The chemiluminescent peroxyoxalate system: state of the art almost 50 years from its discovery. | |
| Jiang et al. | Bright near-infrared circularly polarized electrochemiluminescence from Au 9 Ag 4 nanoclusters | |
| David et al. | N-Arylated bisferrocene pyrazole for the dual-mode detection of hydrogen peroxide: an AIE-active fluorescent “turn ON/OFF” and electrochemical non-enzymatic sensor | |
| Gao et al. | Xanthamide fluorescent dyes | |
| WO2001063265A1 (en) | Measuring method using long life fluorescence of excitation type | |
| Zhang et al. | Design, synthesis and characterization of a novel fluorescent probe for nitric oxide based on difluoroboradiaza-s-indacene fluorophore | |
| Song et al. | Synthesis and time-resolved fluorimetric application of a europium chelate-based phosphorescence probe specific for singlet oxygen | |
| Ma et al. | Platinum (II) complex with excellent electrochemiluminescence properties for the sensitive detection of glutathione and glutathione reductase activities | |
| CN106008510B (zh) | 用于检测Hg2+的聚集诱导发光型荧光传感器及其制备方法和应用 | |
| CN107383078A (zh) | 苯基硼酸酯化合物及包含该化合物的过氧化苯甲酰检测试剂盒 | |
| CN101200447B (zh) | 双功能化学化合物、其制备方法、其用于核酸检测的用途和含有该化合物的系统 | |
| Sun et al. | The construction of an effective far-red fluorescent and colorimetric platform containing a merocyanine core for the specific and visual detection of thiophenol in both aqueous medium and living cells | |
| Rostron et al. | Engineering of an electronically decoupled difluoroindacene-pyrene dyad possessing high affinity for DNA | |
| Shen et al. | Heterogeneous electrochemiluminescence spectrometry of Ru (bpy) 32+ for determination of trace DNA and its application in measurement of gene expression level | |
| CN115677573B (zh) | 一种基于荧光指示剂置换法gtp识别三足阴离子受体及其制备方法和应用 | |
| Zhang et al. | Development of a triple channel detection probe for hydrogen peroxide | |
| Sivakumar et al. | Role of intermolecular charge transfer towards fluorometric detection of fluoride ions with anthrapyrazolone derivatives | |
| CN103980728B (zh) | 一类用于汞离子检测的尼罗蓝荧光染料 | |
| AU2002215610B2 (en) | Electrochemiluminescence from acridan compounds | |
| JP2009234934A (ja) | 電気化学発光物質の発光で蛍光物質を励起する化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050816 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051115 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060213 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061107 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20061128 Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20061128 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070205 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070402 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070501 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070626 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070717 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100727 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110727 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110727 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120727 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130727 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |